May 3, 2011 12:08 pm by Frank Vinluan | 0 Comments
Molecular diagnostics company MDxHealth and partner NovioGendix have been awarded a $1.1 million grant that will be applied toward research and development of a new bladder cancer diagnostic.Belgium-based MDxHealth (BRU:MDXH), ...
Read more